Two new caffeic acid ester derivatives, caffeic acid-4-(2-hydroxyethyl) morpholine ester (Z-1) and caffeic acid-4(3-hydroxypropyl) morpholine ester (Z-2), were synthesized, and their structures were characterized by LC MS, IR, and H-1 NMR. The activation effects of the two compounds on tyrosinase activity were evaluated. Compounds Z-1 and Z-2 showed potent activation effects, and their EC50 values were determined to be 0.075 and 0.0375 mmol/L, respectively. Moreover, the activation mechanism was determined to be of noncompetitive activation type. Interactions of the two compounds with tyrosinase were further analyzed by fluorescence quenching and molecular simulation assays. The results indicated that the effects on the tyrosinase activity were relative to the length of the carbon chain of the compounds. In addition, human M14 melanoma cells showed increased intracellular tyrosinase activity after treatment with the two compounds for 24 h. The expressions of TYR, TRP-1, TRP-2, and alpha-MSH proteins were upregulated in a dose-dependent manner during a 24-h treatment. These results suggested that compounds Z-1 and Z-2 might represent a novel approach for an effective therapy for diseases associate with tyrosinase dysfunction, such as vitiligo and hair graying.